GlassScriptPhysician profile
Parthiv Shah
NPI 1932323409
$35,355.97
in general payments reported to CMS, 2019-2025
7 companies · $13K in 2025
The $13K reported for 2025 was more than what 83% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $131 · 2021: $38.01 · 2022: $6,325 · 2023: $1,963 · 2024: $14K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,050.00 |
| Food and Beverage | $670.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $21,000.00 | 2022-2024 | Carto 3 |
| Biosense Webster, INC. | $12,555.71 | 2019-2025 | Carto 3 |
| Abbott Laboratories | $1,199.66 | 2021-2023 | Mitraclip |
| Boston Scientific Corporation | $276.21 | 2019-2025 | Farapulse |
| E.R. Squibb & Sons, L.L.C. | $267.23 | 2023-2025 | Camzyos |
| Glaxosmithkline, LLC. | $45.21 | 2025 | Nucala |
| Atricure, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parthiv Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.